Urology · Wooster, OH
NPI
1467642496
Since 2007
Specialty
Urology
Code 208800000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
1761 Beall Ave Ste 103
Wooster, OH, 44691
Phone (330) 263-8733
Groups this clinician bills Medicare through
Medicare paid, 2024
$125K
2,490 services
Medicare patients, 2024
418
Average age 75
Drug cost, 2024
$799K
3,045 prescriptions
Company payments, 2025
$202
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Holly K Wyneski was code 81003 (clinical chemistry), 582 times for 325 patients. In total Holly K Wyneski billed 2,490 services in 50 codes, and Medicare paid $125K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-04-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 81003 Clinical Chemistry | Office | 582 | 325 | $2.20 | $1,278 |
| 99214 Office E&M - Established | Office | 508 | 270 | $79.90 | $41K |
| 51798 Ultrasound - Nonspecific | Office | 438 | 282 | $6.77 | $2,967 |
| 99213 Office E&M - Established | Office | 231 | 171 | $54.30 | $13K |
| 64566 Musculoskeletal | Office | 149 | 14 | $73.67 | $11K |
| 99204 Office E&M - New | Office | 94 | 94 | $107.79 | $10K |
| 81001 Clinical Chemistry | Office | 79 | 69 | $3.11 | $246 |
| 52000 Cystourethroscopy | Office | 58 | 58 | $158.52 | $9,194 |
| 99212 Office E&M - Established | Office | 54 | 35 | $36.99 | $1,998 |
| 99205 Office E&M - New | Office | 25 | 25 | $118.94 | $2,974 |
| 51797 Other Organ Systems | Office | 22 | 21 | $124.51 | $2,739 |
| A4562 Pessary, reusable, non rubber, any type | Office | 21 | 18 | $46.11 | $968 |
| 57160 Other Organ Systems | Office | 21 | 21 | $45.09 | $947 |
| 51784 Neurologic | Office | 20 | 19 | $21.77 | $435 |
| 99203 Office E&M - New | Office | 16 | 16 | $61.93 | $991 |
By year: 2022 $133K for 2,202 services; 2023 $132K for 2,448 services; 2024 $125K for 2,490 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 582 | 325 | $2.20 | $1,278 |
| 81001 Clinical Chemistry | 79 | 69 | $3.11 | $246 |
Medicare prescription drug claims, 2024
In 2024, the drug Holly K Wyneski prescribed most often to Medicare patients was Gemtesa (Vibegron), with 641 prescriptions and refills. In total Holly K Wyneski wrote 3,045 Medicare prescriptions that cost $799K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gemtesa Vibegron | 641 | 1,138 | 169 | $527K |
| Cephalexin Generic | 565 | 935 | 276 | $3,435 |
| Estradiol Generic | 266 | 625 | 138 | $17K |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 234 | 234 | 134 | $2,090 |
| Fesoterodine Fumarate Er Fesoterodine Fumarate | 228 | 380 | 67 | $27K |
| Myrbetriq Mirabegron | 178 | 303 | 57 | $168K |
| Trimethoprim Generic | 109 | 261 | 43 | $8,159 |
| Fluconazole Generic | 97 | 97 | 71 | $484 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 75 | 191 | 29 | $2,408 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 70 | 70 | 42 | $173 |
| Solifenacin Succinate Generic | 65 | 157 | 20 | $2,047 |
| Metronidazole Generic | 63 | 63 | 54 | $369 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 54 | 70 | 35 | $211 |
| Ciprofloxacin Hcl Generic | 50 | 50 | 41 | $135 |
| Desmopressin Acetate Generic | 41 | 65 | Under 11 | $2,586 |
Brand drugs: - claims; generic drugs: 2,053 claims; opioid claims: 81.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Holly K Wyneski $202 ($202 in general payments such as food, travel and fees) from 5 companies. The largest payer was Boston Scientific Corporation with $68.68.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.